Sure Med Compliance, a digital healthcare company focused on curbing the opioid-related overdose epidemic announces a partnership with Galt Phranchise Systems (GPS), the first and only franchisor that enables an entrepreneur or business entity to market and promote pharmaceutical and health-related products in their local markets.

Both organizations have an aligned mission in supporting healthcare providers in the fight against the opioid epidemic through safer prescribing practices. Sure Med Compliance seeks to improve patient and provider outcomes in pain management settings through Perspectives in Caresm (PIC), it's scientifically validated electronic patient-reported outcome (ePRO platform), while GPS partner, Galt Pharmaceuticals, is the manufacturer of a non-opioid combination prescription product for acute mild-moderate pain, that is a vital therapeutic option for healthcare providers.

Speaking on the partnership, John Bowman, CEO of Sure Med Compliance, said, "Strategies aimed at solving the current overdose epidemic must go beyond the identification of risk. To be effective, solutions must include making patients and providers aware of products that have the potential to decrease their reliance on non-novel opioid therapies. Our partnership with Galt Phranchise Systems aligns with our commitment to only partner with mission-based organizations that have the potential to improve outcomes in pain management settings."

Barry Patel, Galt CEO and Co-Founder, was quoted as saying "We are excited about our partnership with Sure Med Compliance because their state-of-the art reporting platform can identify patients at risk for opioid abuse, and we have a non-opioid pain medication that can help these patients. Through our partnership with Sure Med, Galt franchisees can build valuable relationships with pain management prescribers within their territories to educate them and support better outcomes for their patients."